[1]Vounzoulaki E, Khunti K, Abner S C, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis[J]. BMJ,2020,369:m1361.
[2]Lowe W J, Scholtens D M, Kuang A, et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS):maternal gestational diabetes mellitus and childhood glucose metabolism[J]. Diabetes Care,2019,42(3):372-380.
[3]Hod M, Kapur A, Sacks D A, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care[J]. Int J Gynaecol Obstet,2015,131(Suppl 3):S173-S211.
[4]Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis[J]. Hypertens Res, 2017, 40(3):213-220.
[5]Gao C, Sun X, Lu L, et al. Prevalence of gestational diabetes mellitus in the Chinese Mainland: a systematic review and meta-analysis[J]. J Diabetes Investig, 2019, 10(1):154-162.
[6]Prakash G, Das A, Habeebullah S, et al. Maternal and neonatal outcome in mothers with gestational diabetes mellitus[J]. Indian J Endocrinol Metab, 2017, 21(6):854.
[7]Chen X, Scholl T O, Leskiw M, et al. Differences in maternal circulating fatty acid composition and dietary fat intake in women with gestational diabetes mellitus or mild gestational hyperglycemia[J]. Diabetes Care, 2010, 33(9):2049-2054.
[8]Villafan-Bernal J R, Acevedo-Alba M, Reyes-Pavon R, et al. Plasma levels of free fatty acids in women with gestational diabetes and its intrinsic and extrinsic determinants: systematic review and meta-analysis[J]. J Diabetes Res, 2019, 2019:1-13.
[9]American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021[J]. Diabetes Care, 2021, 44(Suppl 1):S15-S33.
[10]Karpe F, Dickmann J R, Frayn K N. Fatty acids, obesity, and insulin resistance: time for a reevaluation[J]. Diabetes, 2011, 60(10):2441-2449.
[11]杨旭,路春梅,范春燕,等. 妊娠期糖尿病游离脂肪酸与血糖及血脂代谢的关系[J]. 中国实验诊断学,2021,25(12):1812-1814.
[12]Catalano P M, Nizielski S E, Shao J, et al. Downregulated IRS-1 and PPARγ in obese women with gestational diabetes: relationship to FFA during pregnancy[J]. Am J Physiol Endocrinol Metab, 2002, 282(3):E522-E533.
[13]Pan X, Huang Y, Li X, et al. Circulating fatty acids and risk of gestational diabetes mellitus: prospective analyses in China[J]. Eur J Endocrinol, 2021, 185(1):87-97.
[14]Zhu Y, Tsai M Y, Sun Q, et al. A prospective and longitudinal study of plasma phospholipid saturated fatty acid profile in relation to cardiometabolic biomarkers and the risk of gestational diabetes[J]. Am J Clin Nutr, 2018, 107(6):1017-1026.
[15]Hou W, Meng X, Zhao A, et al. Development of multimarker diagnostic models from metabolomics analysis for gestational diabetes mellitus (GDM)[J]. Mol Cell Proteomics, 2018, 17(3):431-441.
[16]Zhu Y, Li M, Rahman M L, et al. Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: a longitudinal study within the prospective NICHD Fetal Growth Studies[J]. PLoS Med,2019,16(9):e1002910.
[17]Retnakaran R, Qi Y, Sermer M, et al. β-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy[J]. Diabetes Care, 2010, 33(8):1798-1804.
[18]Chen X, Stein T P, Steer R A, et al. Individual free fatty acids have unique associations with inflammatory biomarkers, insulin resistance and insulin secretion in healthy and gestational diabetic pregnant women[J]. BMJ Open Diabetes Res Care, 2019, 7(1):e632.
[19]Festuccia W T. Regulation of adipocyte and macrophage functions by mTORC1 and 2 in metabolic diseases[J]. Mol Nutr Food Res, 2021, 65(1):e1900768.
[20]Tang S, Luo F, Feng Y M, et al. Neutral ceramidase secreted via exosome protects against palmitate-induced apoptosis in INS-1 cells[J]. Exp Clin Endocrinol Diabetes, 2017, 125(2):130-135.
[21]Marmugi A, Parnis J, Chen X, et al. Sorcin links pancreatic beta-cell lipotoxicity to ER Ca2+ stores[J]. Diabetes, 2016, 65(4):1009-1021.
[22]Macchioni L, Petricciuolo M, Davidescu M, et al. Palmitate lipotoxicity in enteric glial cells: Lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2018, 1863(8):895-908.
[23]Shang W, Yasuda K, Takahashi A, et al. Effect of high dietary fat on insulin secretion in genetically diabetic Goto-Kakizaki rats[J]. Pancreas, 2002, 25(4):393-399.
[24]Tang Y, Wallace M, Sanchez-Gurmaches J, et al. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism[J]. Nat Commun, 2016,7: 11365.
[25]Hodge A M, English D R, ODea K, et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid[J]. Am J Clin Nutr, 2007, 86(1):189-197.
[26]Tricò D, Mengozzi A, Nesti L, et al. Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis[J]. Diabetologia, 2020, 63(1):206-218.
[27]Rainer L, Heiss C J. Conjugated linoleic acid: health implications and effects on body composition[J]. J Am Diet Assoc, 2004, 104(6):963-968, 1032.
[28]Hegazy M, Elsayed N M, Ali H M, et al. Diabetes mellitus, nonalcoholic fatty liver disease, and conjugated linoleic acid (Omega 6):what is the link?[J]. J Diabetes Res, 2019, 2019:5267025.
|